Gene · 155
Papers3,802
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,802
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| GPR84-mediated signal transduction affects metabolic function by promoting brown adipocyte activity. | J Clin Invest | 2023 | 37856216 | PubTator, text mining | PubMed |
| Distinct Conformations of Mirabegron Determined by MicroED. | Adv Sci (Weinh) | 2023 | 37847906 | PubTator, text mining | PubMed |
| Epigenetic Biomarkers of Metabolic Responses to Lifestyle Interventions. | Nutrients | 2023 | 37836535 | PubTator, text mining | PubMed |
| Genomic Biomarker Discovery in Disease Progression and Therapy Response in Bladder Cancer Utilizing Machine Learning. | Cancers (Basel) | 2023 | 37835496 | PubTator, text mining | PubMed |
| Targeting the Cancer-Neuronal Crosstalk in the Pancreatic Cancer Microenvironment. | Int J Mol Sci | 2023 | 37834436 | PubTator, text mining | PubMed |
| Effects of Weight Loss and Aerobic Exercise Training on Adi-Pose Tissue Zinc α2-Glycoprotein and Associated Genes in Obesity. | Cells | 2023 | 37830580 | PubTator, text mining | PubMed |
| Characterization of the lncRNA-mediated ceRNA regulatory networks in preeclampsia by integrated bioinformatics. | Sci Rep | 2023 | 37828060 | PubTator, text mining | PubMed |
| An update on diagnosis and therapeutics for type-2 diabetes mellitus. | Bioinformation | 2023 | 37808382 | PubTator, text mining | PubMed |
| Comparative Study Between Behavior Therapy and Behavior Therapy Plus Mirabegron 50 mg in Sexually Active Men With Bothersome Overactive Bladder Symptoms - A Multicenter, Randomized Study. | Int Neurourol J | 2023 | 37798885 | PubTator, text mining | PubMed |
| Identifying G protein-coupled receptors involved in adipose tissue function using the innovative RNA-seq database FATTLAS. | iScience | 2023 | 37766984 | PubTator, text mining | PubMed |
| Brown Fat and Nutrition: Implications for Nutritional Interventions. | Nutrients | 2023 | 37764855 | PubTator, text mining | PubMed |
| Could Natural Products Help in the Control of Obesity? Current Insights and Future Perspectives. | Molecules | 2023 | 37764380 | PubTator, text mining | PubMed |
A Systematic Review and Meta-Analysis of Free Triiodothyronine (FT3) Levels in Humans Depending on Seasonal Air Temperature Changes: Is the Variation in FT3 Levels Related to Nonshivering Thermogenesis? | Int J Mol Sci | 2023 | 37762355 | PubTator, text mining | PubMed |
| Bacterial lipopolysaccharide related genes signature as potential biomarker for prognosis and immune treatment in gastric cancer. | Sci Rep | 2023 | 37741901 | PubTator, text mining | PubMed |
| Secondary diabetes mellitus in pheochromocytomas and paragangliomas. | Endocrine | 2023 | 37731140 | PubTator, text mining | PubMed |
| Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease: The Beta3-LVH Phase 2b Randomized Clinical Trial. | JAMA Cardiol | 2023 | 37728907 | PubTator, text mining | PubMed |
| Clinical pharmacology of β-3 adrenergic receptor agonists for cardiovascular diseases. | Expert Rev Clin Pharmacol | 2023 | 37728503 | PubTator, text mining | PubMed |
| Patient and Clinician Challenges with Anticholinergic Step Therapy in the Treatment of Overactive Bladder: A Narrative Review. | Adv Ther | 2023 | 37725308 | PubTator, text mining | PubMed |
| Effects of a new selective β3 -adrenoceptor agonist, vibegron, on bladder and urethral function in a rat model of Parkinson's disease. | Low Urin Tract Symptoms | 2023 | 37721189 | PubTator, text mining | PubMed |
| Gut microbiota turn up the heat after bariatric surgery. | Cell Stress | 2023 | 37693093 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/155/papers?page=13